World Intravenous (IV) Ibuprofen Market : Future Trends and Best Regions to Focus Globally!

1
World Intravenous (IV) Ibuprofen Market
Published on 01 April, 2016 Number of pages
65 Single User Price 4740
World Intravenous (IV) Ibuprofen Market Market
by Manufacturers, Regions, Type and Application,
Forecast to 2021
Click Here To Check Complete Report
2
Intravenous (IV) ibuprofen is a non-steroidal
anti-inflammatory drug (NSAID) used to reduce or
treat pain, fever, and inflammation occurred due
to a disease, operative procedures or trauma, and
acute illness. The intravenous (IV) route for
ibuprofen administration has a faster onset of
action as compared to the other routes. IV
ibuprofen is preferred for the management of
post-operative and acute pain. The demand for
ibuprofen has increased due to the side effects
of opioid analgesics such as respiratory
depression, allergic reactions, sedation, and
gastrointestinal events. The market for IV
ibuprofen for pain management is in its nascent
stage. The world IV ibuprofen market was valued
at 3.6 million in 2015, and is projected to
reach 14.2 million by 2022, registering a CAGR
of 20 during the forecast period.  Advantages
associated with IV ibuprofen such as rapid result
and targeted drug delivery have resulted in the
growth of this market. In 2015, FDA approved IV
ibuprofen for pediatric use, due to which the
market is expected to register a significant
growth during the forecast period.
Avail more information from Sample Brochure of
report
3
Other factors that affect the market growth
significantly include increasing incidence of
cancer, cardiovascular ailments, pain, headache,
toothache, back pain, arthritis, trauma, and
shifting trend towards the use of non-opioids
drugs. Factors that would hamper the market
growth include side effects associated with IV
ibuprofen and lengthy approval process.The world
IV Ibuprofen market is segmented on the basis of
indication, age group, and country. By
indication, further sub-segments considered in
this report include pain/inflammation and fever.
The age groups considered are pediatrics and
adults.  The market is segmented into four
countries namely Australia, Canada, South Korea,
and the U.S.Currently, Cumberland Pharmaceuticals
Inc., is the only IV ibuprofen manufacturer in
the market. The company has collaborated with the
local/regional drug manufacturers to target new
countries by getting product approvals.
4
The key companies profiled in this report are
Cumberland Pharmaceuticals Inc., Alveda
Pharmaceuticals, Inc. (acquired by Teligent,
Inc.), CSL Limited, Sandor Medicaids Pvt Ltd.,
PT. Soho Industri Pharmasi, Germin MED, Grifols
S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al
Nabeel International Ltd., and Laboratorios
Valmorca, C.A.KEY BENEFITS FOR STAKEHOLDERSThis
report provides an extensive analysis of the
current and emerging trends and dynamics in the
world IV Ibuprofen market.The world IV Ibuprofen
market is analyzed based on countries such as the
U.S., Australia, Canada and South Korea.The study
evaluating competitive landscape has been taken
into account to understand the competitive
environment across the countries considered.This
report provides detailed quantitative analysis of
the current market and estimations from 2015 to
2022, which assists to identify the prevailing
opportunities.Exhaustive analysis of the world IV
Ibuprofen market by indication describes the
types of indications that will gain prominence in
future.INTRAVENOUS (IV) IBUPROFEN MARKET KEY
SEGMENTSBy IndicationPain/InflammatoryFeverBy
Age GroupPediatricsAdultsBy CountryAustraliaCanada
South KoreaU.S.
5
World Intravenous (IV) Ibuprofen Market Market
by Manufacturers, Regions, Type and Application,
Forecast to 2021
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
World Intravenous (IV) Ibuprofen Market Market
by Manufacturers, Regions, Type and Application,
Forecast to 2021 and future opportunities are
provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of World Intravenous
(IV) Ibuprofen Market Report